Summary
- Current Price
- As of today, ELTX price is $12.99, up +10.65% on
- Current Price All-Time High
- ELTX price is currently -95.06% below its historical high of $263.00 set on
- Market Cap
- ELTX current market cap is $224M, up +124.91% over the past 365 days
- PE Ratio
- ELTX PE ratio is unknown
- Revenue
- ELTX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for ELTX has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Elicio Therapeutics, Inc. |
| Ticker | NASDAQ: ELTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | elicio.com |
| Employees | 32 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $12.99 | ||
| Price, 1D Change | +10.65% | |
| $224M | ||
| - | ||
| - | ||
| 0.33 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$4.25 | ||
| EPS, 1Y Change | +38.90% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | ANGN | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$4.25 | ||
| EPS Estimate | N/A | -$2.51 |
| EPS Est. Change | N/A | +41.10% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $12.99 | ||
| Price Target | - | $15.50 |
| Price Tgt. Change | - | +19.32% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$5.45 | -$6.96 | -27.72% | |
| -$4.07 | -$4.25 | -4.62% | |
| -$2.51 | N/A | +41.10% | |
| -$1.51 | N/A | +64.61% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +57.07% | ||
| +96.82% | ||
| +124.91% | ||
| +1,027.99% | ||
| 0.00% | ||
| -100.00% | ||
| +38.90% | ||
| +77.99% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $12.99 | ||
| $8.99 | ||
| SMA 200 vs Price | -30.77% | |
| $8.45 | ||
| SMA 50 vs Price | -34.97% | |
| 0.33 | ||
| $0.83 | ||
| 82.01 | ||
| 70.35% | ||
| 77.65% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$4.25 | ||
| -$1.18M | ||
| - | ||
| -$44.99M | ||
| - | ||
| -$51.90M | ||
| - | ||
| -$43.81M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -2.30 | ||
| 1.80 | ||
| 1.80 | ||
| - | ||
| - | ||
| -11.12 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 58.75 | ||
| -5.31 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$11.31M | ||
| $18.80M | ||
| $28.18M | ||
| $20.69M | ||
| $39.49M | ||
| $11.52M | ||
| $26.04M | ||
| $901.00K | ||
| $1.04M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $51.90M | ||
| $43.81M | ||
| $1.18M | ||
| $0.00 | ||
| $1.18M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$37.07M | ||
| -$84.00K | ||
| $42.32M | ||
| $87.00K | ||
| -$37.16M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Jones Trading | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Oppenheimer | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with ELTX
FAQ
What is the ticker symbol for Elicio Therapeutics, Inc.?
The ticker symbol for Elicio Therapeutics, Inc. is NASDAQ:ELTX
Does Elicio Therapeutics, Inc. pay dividends?
No, Elicio Therapeutics, Inc. does not pay dividends
What sector is Elicio Therapeutics, Inc. in?
Elicio Therapeutics, Inc. is in the Healthcare sector
What industry is Elicio Therapeutics, Inc. in?
Elicio Therapeutics, Inc. is in the Biotechnology industry
What country is Elicio Therapeutics, Inc. based in?
Elicio Therapeutics, Inc. is headquartered in United States
When did Elicio Therapeutics, Inc. go public?
Elicio Therapeutics, Inc. initial public offering (IPO) was on February 5, 2021
Is Elicio Therapeutics, Inc. in the S&P 500?
No, Elicio Therapeutics, Inc. is not included in the S&P 500 index
Is Elicio Therapeutics, Inc. in the NASDAQ 100?
No, Elicio Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Elicio Therapeutics, Inc. in the Dow Jones?
No, Elicio Therapeutics, Inc. is not included in the Dow Jones index
When was Elicio Therapeutics, Inc. last earnings report?
Elicio Therapeutics, Inc.'s most recent earnings report was on November 13, 2025
When does Elicio Therapeutics, Inc. report earnings?
The date for Elicio Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- ELTX Official Website elicio.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1601485/000160148525000124/0001601485-25-000124-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1601485/000160148525000049/0001601485-25-000049-index.htm
- ELTX Profile on Yahoo Finance finance.yahoo.com/quote/ELTX
- ELTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/eltx